| 标题 |
 Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊：Lancet Oncol 作者：Robak T, Jin J, Pylypenko H, Verhoef G, Siritanaratkul N, Drach J, Raderer M, Mayer J, Pereira J, Tumyan G, Okamoto R, Nakahara S, Hu P, Appiani C, Nemat S, Cavalli F, LYM-3002 investigators 出版日期：2018-10-19 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
cdercder
yjh123
东方元语
Kao
张欢馨
OK
dde
炜大的我
Hayat
小小牛马
sagitar
aajhajkahna
科研狗
行走的荷尔蒙
xing_xing
天晴
柒姐
啵啵
Criminology34
皖公网安备34019202002308
